January 1, 2016Open Access

The risk factors for cytomegalovirus reactivation following stem cell transplantation

Key Points

Key points are not available for this paper at this time.

Abstract

We found that the significant risk factor for CMV antigenemia in multivariate analysis was prior graft-versus-host disease (GVHD) experience and higher donor age. For high-level antigenemia, GVHD or duration of its treatment was significant determinant.

Read Full Paperexternally

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Hadjibabaie et al. (Fri,) studied this question.

synapsesocial.com/papers/69d742108e958094d1b8a94a https://doi.org/https://doi.org/10.4103/2279-042x.176554

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation2011 · 53 citations
2Biobehavioral influences on recovery following hematopoietic stem cell transplantation2012 · 79 citations
3Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease1986 · 264 citations
4Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease1986 · 16 citations
5Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia2003 · 33 citations

Demander à l'IA

Bookmark

View Full Paper